 SALT LAKE CITY, Sept. 23, 2021 PRNewswire -- Co-Diagnostics, Inc. Nasdaq: CODX the Company, a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that following its recent transformative growth, the Company is rebranding its image to better reflect its expanded scope, mission, and upcoming expansion into new diagnostics verticals. 